Methicillin‐resistant Staphylococcus aureus (MRSA) infections among HIV‐infected persons in the era of highly active antiretroviral therapy: a review of the literature
Authors:
- 25 January 2012
- journal article
- review article
- Published by Wiley in HIV Medicine
- Vol. 13 (6) , 319-332
Abstract
Objectives: Despite the rise of methicillin‐resistant Staphylococcus aureus (MRSA) skin and soft tissue infections (SSTIs) among HIV‐infected persons during the era of highly active antiretroviral therapy (HAART), the precise relationship between these two infections has not been fully elucidated. Therefore, we provide a comprehensive, literature‐based review of MRSA infections among HIV‐infected persons.Methods: A systematic search of MEDLINE using the search terms “HIV” and “MRSA” identified references published during the HAART era (January 1996 to January 2011). Relevant articles on MRSA in the general population were also reviewed for comparison.Results: The most common type of MRSA infection among HIV‐infected persons is SSTI caused by USA300, Panton‐Valentine leukocidin (PVL)‐positive strains. HIV‐infected persons have an increased risk for both initial MRSA infections and recurrent infections compared with the general population. Risk factors for MRSA infections in this population include immunosuppression, comorbid conditions and certain lifestyle behaviours such as high‐risk sexual behaviours and illicit drug use. Further research is needed on the optimal treatment and prevention strategies for MRSA infections among HIV‐infected persons.Conclusions: HIV‐infected persons have a propensity for MRSA SSTI and a high rate of recurrent disease. The reasons for the elevated rates of MRSA infections among HIV‐infected persons appear to be multifactorial, but may be mitigated with optimized HIV control and reductions in associated risk factors.Keywords
This publication has 64 references indexed in Scilit:
- Recurrent Community-Acquired Methicillin-Resistant Staphylococcus aureus Infections in an HIV-Infected PersonJournal of Clinical Microbiology, 2011
- The NOSE Study (Nasal Ointment for Staphylococcus aureus Eradication): A Randomized Controlled Trial of Monthly Mupirocin in HIV-Infected IndividualsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Association of methicillin-resistant Staphylococcus aureus (MRSA) USA300 genotype with mortality in MRSA BacteremiaJournal of Infection, 2010
- Short Communication: Methicillin-Resistant Staphylococcus aureus Infections in Children and Young Adults Infected with HIVAIDS Research and Human Retroviruses, 2009
- Recurrent Community-Associated Methicillin-Resistant Staphylococcus aureus Infections among HIV-Infected Persons: Incidence and Risk FactorsAIDS Patient Care and STDs, 2009
- Antibiotic resistance in Staphylococcus aureus–containing cutaneous abscesses of patients with HIVThe American Journal of Emergency Medicine, 2009
- The incidence of and risk factors for MRSA bacteraemia in an HIV‐infected cohort in the HAART era*HIV Medicine, 2008
- Severe Necrotizing Fasciitis in a Human Immunodeficiency Virus-Positive Patient Caused by Methicillin-Resistant Staphylococcus aureusJournal of Clinical Microbiology, 2008
- Role of previous hospitalization in clinically-significant MRSA infection among HIV-infected inpatients: results of a case-control studyBMC Infectious Diseases, 2007
- Treatment and Outcomes of Infections by Methicillin-Resistant Staphylococcus aureus at an Ambulatory ClinicAntimicrobial Agents and Chemotherapy, 2007